Literature DB >> 12107925

[Physiopathology of aortic aneurysm].

Patrick Rossignol1, Vincent Fontaine, Olivier Meilhac, Eduardo Anglés-Cano, Marie-Paule Jacob, Jean-Baptiste Michel.   

Abstract

Aneurysm is an arterial dilatation with risk of rupture. It is a disease of the media characterized by the destruction of extracellular matrix proteins (especially elastin) involving different proteases: matrix metalloproteinases, fibrinolytic proteases (plasminogen activators, plasmin), leucocyte elastase, and by the absence of scarring process. There is an imbalance in the aortic wall between proteolytic and antiproteolytic activities, the former being overexpressed (by inflammatory cells infiltrating the aortic wall on the adventitial side, and the endoluminal thrombus), the latter (normally synthesized and secreted by vascular smooth muscle cells) being decreased in relation to the disappearance of smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107925

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  3 in total

1.  Effects of different stent wire mesh densities on hemodynamics in aneurysms of different sizes.

Authors:  Shunsuke Masuda; Soichiro Fujimura; Hiroyuki Takao; Kohei Takeshita; Takashi Suzuki; Yuya Uchiyama; Kostadin Karagiozov; Toshihiro Ishibashi; Koji Fukudome; Makoto Yamamoto; Yuichi Murayama
Journal:  PLoS One       Date:  2022-06-10       Impact factor: 3.752

Review 2.  Delayed hemorrhagic complications after flow diversion for intracranial aneurysms: a literature overview.

Authors:  Aymeric Rouchaud; Waleed Brinjikji; Giuseppe Lanzino; Harry J Cloft; Ramanathan Kadirvel; David F Kallmes
Journal:  Neuroradiology       Date:  2015-11-09       Impact factor: 2.804

3.  Concomitant coiling reduces metalloproteinase levels in flow diverter-treated aneurysms but anti-inflammatory treatment has no effect.

Authors:  Evan Thielen; Megan McClure; Aymeric Rouchaud; Yong-Hong Ding; Daying Dai; Dana Schroeder; Juan Cebral; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2016-03-14       Impact factor: 5.836

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.